114 related articles for article (PubMed ID: 8429106)
1. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy.
Kuroda Y; Matsui M
J Neuroimmunol; 1993 Feb; 42(2):223-6. PubMed ID: 8429106
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy.
Furuya T; Nakamura T; Fujimoto T; Nakane S; Kambara C; Shirabe S; Hamasaki S; Motomura M; Eguchi K
J Neuroimmunol; 1999 Mar; 95(1-2):185-9. PubMed ID: 10229129
[TBL] [Abstract][Full Text] [Related]
3. HTLV-1 antibodies in serum and cerebrospinal fluid in tropical spastic paraparesis in Brazil.
Spina-França A; Livramento JA; Machado LR; Gomes HR; Vianna LS; Castro LH; Nóbrega JP; Bacheschi LA
Arq Neuropsiquiatr; 1990 Dec; 48(4):441-7. PubMed ID: 2094190
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nishimoto N; Yoshizaki K; Eiraku N; Machigashira K; Tagoh H; Ogata A; Kuritani T; Osame M; Kishimoto T
J Neurol Sci; 1990 Jul; 97(2-3):183-93. PubMed ID: 2401896
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy.
Kuroda Y; Matsui M; Takashima H; Kurohara K
J Neuroimmunol; 1993 Jun; 45(1-2):133-6. PubMed ID: 8331158
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy.
Fujimoto T; Nakamura T; Furuya T; Nakane S; Shirabe S; Kambara C; Hamasaki S; Yoshimura T; Eguchi K
Intern Med; 1999 Sep; 38(9):717-21. PubMed ID: 10480302
[TBL] [Abstract][Full Text] [Related]
7. Chronic progressive myelopathy associated with HTLV-I: oligoclonal IgG and anti-HTLV-I IgG antibodies in cerebrospinal fluid and serum.
Link H; Cruz M; Gessain A; Gout O; de Thé G; Kam-Hansen S
Neurology; 1989 Dec; 39(12):1566-72. PubMed ID: 2586770
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.
Takatani M; Crispim ME; Fraiji N; Stefani MM; Kiesslich D
Rev Inst Med Trop Sao Paulo; 2017 Apr; 59():e5. PubMed ID: 28380116
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
10. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
11. HTLV-I associated myelopathy in patients from Brazil and Iran: neurological manifestations and cerebrospinal fluid findings.
Puccioni-Sohler M; Kitze B; Felgenhauer K
Arq Neuropsiquiatr; 1995 Jun; 53(2):213-7. PubMed ID: 7487526
[TBL] [Abstract][Full Text] [Related]
12. Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
Guerreiro JB; Santos SB; Morgan DJ; Porto AF; Muniz AL; Ho JL; Teixeira AL; Teixeira MM; Carvalho EM
Clin Exp Immunol; 2006 Aug; 145(2):296-301. PubMed ID: 16879249
[TBL] [Abstract][Full Text] [Related]
13. [Oligoclonal IgG bands in patients with HTLV-I associated myelopathy--detection by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining].
Saito T; Osame M; Usuku K; Matsumoto M; Igata A
Rinsho Shinkeigaku; 1989 Aug; 29(8):976-81. PubMed ID: 2689034
[TBL] [Abstract][Full Text] [Related]
14. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients.
Cartier L; Ramirez E
Arch Virol; 2005 Apr; 150(4):743-53. PubMed ID: 15592888
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of HTLV-I-associated myelopathy with alpha-interferon and high-dose of gamma-globulin].
Kuroda Y; Takashima H; Endo C; Neshige R; Kakigi R
Rinsho Shinkeigaku; 1990 Jun; 30(6):594-8. PubMed ID: 1699697
[TBL] [Abstract][Full Text] [Related]
16. Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Ohta M; Ohta K; Nishimura M; Saida T
Ann Clin Biochem; 2002 Nov; 39(Pt 6):603-5. PubMed ID: 12564844
[TBL] [Abstract][Full Text] [Related]
17. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
[TBL] [Abstract][Full Text] [Related]
18. A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseases.
Puccioni-Sohler M; Rieckmann P; Kitze B; Lange P; Albrecht M; Felgenhauer K
J Neurol; 1995 Mar; 242(4):239-42. PubMed ID: 7798123
[TBL] [Abstract][Full Text] [Related]
19. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy.
Nakamura S; Nagano I; Yoshioka M; Shimazaki S; Onodera J; Kogure K
J Neuroimmunol; 1993 Feb; 42(2):127-30. PubMed ID: 8429097
[TBL] [Abstract][Full Text] [Related]
20. The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis.
Puccioni-Sohler M; Kitze B; Felgenhauer K; Graef IT; Lange P; Novis S; Reiber H; Vaz B
Arq Neuropsiquiatr; 1995 Dec; 53(4):760-5. PubMed ID: 8729769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
